Clinical Trial News and Research

RSS
Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Antibody improves progression-free survival in patients with advanced prostate cancer

Antibody improves progression-free survival in patients with advanced prostate cancer

Phase 1 trial of new class of drugs shows promise in range of advanced cancers

Phase 1 trial of new class of drugs shows promise in range of advanced cancers

Antiacid monotherapy is better than combination therapy in relieving epigastric pain

Antiacid monotherapy is better than combination therapy in relieving epigastric pain

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

New drug offers hope for young boys with Duchenne muscular dystrophy

New drug offers hope for young boys with Duchenne muscular dystrophy

New trial tests combination antibody treatment for preventing COVID-19 illness

New trial tests combination antibody treatment for preventing COVID-19 illness

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

University of Minnesota receives funding to initiate research on diabetes drug as a COVID-19 treatment

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

3D-printed alternative performs as well as the standard nasal swabs for COVID-19 testing

About 10% patients with severe disease create auto-antibodies that attack the immune system

About 10% patients with severe disease create auto-antibodies that attack the immune system

Scientists to use CRISPR gene-editing technology for Phase 1 vaccine trials in humans

Scientists to use CRISPR gene-editing technology for Phase 1 vaccine trials in humans

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

These secret safety panels will pick the COVID vaccine winners

These secret safety panels will pick the COVID vaccine winners

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

Fourth Phase 3 clinical trial evaluating COVID-19 vaccine begins in the U.S.

Early treatment for venous leg ulcers delivers clinical benefits and cost savings

Early treatment for venous leg ulcers delivers clinical benefits and cost savings

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

UEA researchers put virtual reality rehabilitation for stroke survivors to the test

UEA researchers put virtual reality rehabilitation for stroke survivors to the test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.